secwatch.observer — SEC 8-K summary
======================================

Issuer:     Celularity Inc (CELU)
CIK:        0001752828
Form:       8-K
Filed at:   2024-01-17T23:59:59+00:00
Accession:  0000950170-24-005029
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 3.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Celularity raises ~$21M via private placement and secured loan; CEO takes 85% equity compensation
--------------------------------------------------------------------------------

- Private placement with Dragasac raises $6.0M; 21.4M shares and warrants to buy 5.35M shares at $0.24898.
- Senior secured bridge loan from RWI for $15M (net $11.25M after OID), 12.5% PIK interest, matures July 2025.
- Proceeds used to pay off Yorkville debt, critical vendors, Palantir settlement, and for working capital.
- CEO Hariri agrees to 85% equity comp, no cash deferred comp until $21M equity raise at same valuation.
- Existing Dragasac warrants repriced from $6.77 to $0.24898; RWI gets warrants for up to 30M shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1752828/000095017024005029/0000950170-24-005029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1752828/000095017024005029/celu-20240112.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-005029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer